presented two posters during the 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) meeting highlighting continued data for tivozanib, a next-generation vascular endothelial ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...